GEOVAX LABS, INC. Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount
GEOVAX LABS, INC. (GOVX) reported Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount of $10.09 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-26.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate · last filed 2019-03-26
- GEOVAX LABS, INC. effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2017 was $10.09M.
| Period end | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount 12 month |
|---|---|
| 2017-12-31 | $10.09M 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |